Trials / Conditions / Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

341 registered clinical trials studyying Benign Prostatic Hyperplasia — 58 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasi NCT05393921	University Hospitals Cleveland Medical Center	Phase 4
Not Yet Recruiting	Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer NCT07526675	Benha University	N/A
Not Yet Recruiting	RADA16 for Aquablation Day Case NCT06948331	NYU Langone Health	Phase 2
Not Yet Recruiting	Urinary CTGF in Benign Prostatic Obstruction NCT07416981	Tarik Emre Sener	—
Not Yet Recruiting	Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial NCT07467343	Ain Shams University	Phase 4
Recruiting	The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy NCT07214675	HistoSonics, Inc.	N/A
Not Yet Recruiting	Tranexamic Acid for Bleeding Reduction During TURP Surgery NCT07460518	Hamza Najout	Phase 4
Recruiting	A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects NCT07444385	Addpharma Inc.	Phase 1
Recruiting	Ambulatory Long Length URodynamics Evaluation NCT07425015	Bright Uro	N/A
Not Yet Recruiting	A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia NCT07357012	Peking University Third Hospital	—
Not Yet Recruiting	Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly NCT07357714	Chinese PLA General Hospital	—
Recruiting	Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. NCT07293442	Taipei Medical University WanFang Hospital	N/A
Not Yet Recruiting	A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adul NCT07103278	Addpharma Inc.	Phase 1
Not Yet Recruiting	A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment NCT07146386	Shanghai Huilun Pharmaceutical Co., Ltd.	Phase 3
Completed	Comparative Neurocognitive Outcomes Following Prostate Surgery NCT07468084	Cengiz Canakci, MD	—
Completed	Factors Predicting The Success of Ejaculation Sparing Transurethral Resection of Prostate in Benign Prostatic NCT07513896	Ain Shams University	N/A
Recruiting	Local Anesthesia With Schelin Catheter in Rezum Treatment: a Randomized Controlled Trial NCT06657872	Assistance Publique Hopitaux De Marseille	N/A
Recruiting	Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia NCT06852859	Sahlgrenska University Hospital	—
Recruiting	A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia NCT06849258	Rivermark Medical	N/A
Enrolling By Invitation	A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System NCT06965582	ALPFA Medical	N/A
Completed	Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Tr NCT07510685	University of Pisa	N/A
Withdrawn	RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up NCT05784558	NeoTract, Inc.	—
Not Yet Recruiting	Bipolar TURP Versus Bipolar Enucleation for BPH Management NCT06758466	Kasr El Aini Hospital	N/A
Not Yet Recruiting	Research for the Efficacy and Safety of Percutaneous Tibial Nerve Stimulation to Promote Storage Symptoms Post NCT06742489	Zhu Yiping	N/A
Not Yet Recruiting	Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation NCT06710327	Kaiser Permanente	Phase 4
Recruiting	HoLEP vs BipolEP in Management of BPH Patients With Large Prostates NCT06759194	Assiut University	N/A
Completed	Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH NCT07306767	Ain Shams University	—
Recruiting	A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prost NCT06668142	Andromeda Surgical	N/A
Not Yet Recruiting	Comparison of Glue with Microparticles in Prostatic Artery Embolization NCT06678308	Almaviva Sante	N/A
Recruiting	A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Noct NCT07357324	The Fourth Affiliated Hospital of Zhejiang University School of Medicine	Phase 4
Recruiting	Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis NCT06424912	Vivifi Medical	N/A
Recruiting	Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/T NCT06528613	Elpen Pharmaceutical Co. Inc.	—
Recruiting	Sacral Neuromodulation for Male Overactive Bladder (MOAB) NCT06511141	Axonics, Inc.	N/A
Completed	The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analy NCT06589154	Shanghai Changzheng Hospital	—
Not Yet Recruiting	Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia NCT06596590	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	N/A
Not Yet Recruiting	Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia NCT06607094	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	N/A
Recruiting	Evaluating the Safety and Efficacy of the "HIFU" High-intensity Focused Ultrasound Treatment of Benign Prostat NCT06601179	EDAP TMS S.A.	N/A
Completed	A Study to Assess the Effect of Fucoidan on Prostate Health in Males With Benign Prostatic Hyperplasia NCT06487871	Vedic Lifesciences Pvt. Ltd.	N/A
Recruiting	The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia NCT06867315	First Affiliated Hospital of Zhejiang University	N/A
Recruiting	Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Pros NCT06212453	Assistance Publique - Hôpitaux de Paris	Phase 2
Recruiting	Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) vs 26 F Sheath HoLEP for BPH: RCT NCT06546865	Thunder Bay Regional Health Research Institute	N/A
Recruiting	OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH NCT06560476	Urotronic Inc.	—
Recruiting	Evaluation of the Water Vapor Thermal Therapy System for the Treatment of Benign Prostatic Hyperplasia NCT06725212	Medtecx Co Ltd.	N/A
Unknown	Outcomes of MIST for BPH: A Single-Institution Prospective Study NCT06275256	University of Manitoba	Phase 3
Completed	A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tr NCT06504472	Optimale	N/A
Recruiting	Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study NCT06312722	Urotronic Inc.	N/A
Recruiting	European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms NCT06564415	University of Florence	—
Completed	Single Center Comparative Trial of Trans-Perineal Laser Ablation Vs Water Vapor Ablation NCT06794333	University of Pisa	N/A
Recruiting	PRescription Exercise for Older Men With Urinary Disease NCT06225479	University of California, San Francisco	N/A
Terminated	Neuflo System for the Treatment of BPH NCT05884580	ProstaCare Pty Ltd	N/A
Completed	The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS NCT06260917	Ankara City Hospital Bilkent	—
Completed	Music Intervention During AEEP: A Prospective Randomized Controlled Trial NCT07255118	İrfan Şafak Barlas	N/A
Recruiting	Study on Water Vapor Thermal Therapy NCT06656689	Saint Vincent's Hospital, Korea	—
Recruiting	Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH NCT04627701	ProArc Medical	N/A
Unknown	Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP NCT05913466	Benha University	N/A
Recruiting	Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes NCT05898932	Northwestern University	—
Completed	Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia NCT06051383	Amna A. Desouky, MD	N/A
Completed	Is Ejaculation Preservation TURis the Natural Evolution of the "Gold Standard". NCT06263049	Ain Shams University	N/A
Unknown	Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic En NCT05784909	Assiut University	N/A
Recruiting	BPH Global Registry NCT05543200	Société Internationale d'Urologie	—
Recruiting	Effect of Electroacupuncture on Benign Prostatic Hyperplasia NCT05585450	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Withdrawn	Role of Prophylactic Postoperative Antibiotics in HoLEP NCT05274672	Baylor Research Institute	Phase 4
Recruiting	AQUABEAM® Robotic System and Ultrasound Accessories NCT05157529	Centre hospitalier de l'Université de Montréal (CHUM)	N/A
Recruiting	Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH NCT05757687	ProArc Medical	N/A
Terminated	IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation NCT06157164	University of Kansas Medical Center	—
Terminated	Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient NCT04979143	University of Kansas Medical Center	N/A
Active Not Recruiting	PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs NCT06051942	PROCEPT BioRobotics	N/A
Unknown	Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH) NCT05567666	Dean Elterman	N/A
Unknown	Codesign of an Optical Device to Measure Urine Flow and Volume NCT05576311	Teesside University	—
Recruiting	Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate W NCT05574244	University Hospital, Bordeaux	N/A
Active Not Recruiting	Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval NCT05400980	Prodeon Medical, Inc	N/A
Completed	B-TURP vs BipolEP in Management of BPH Patients With Medium-sized Prostates NCT06939062	Assiut University	N/A
Recruiting	Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia NCT05306145	Shanghai East Hospital	N/A
Completed	A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha- NCT07144709	Pierre Fabre Medicament	—
Active Not Recruiting	Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate NCT05155891	University of Miami	N/A
Withdrawn	Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) NCT04563221	Andrew Picel	N/A
Unknown	(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia NCT05236634	Assiut University	N/A
Recruiting	Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH) NCT05240001	Thunder Bay Regional Health Research Institute	N/A
Unknown	Benigh Prosatic Hyperplasia/Lower Urinary Tract Symptoms NCT05288621	The Third Affiliated hospital of Zhejiang Chinese Medical University	N/A
Recruiting	Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong K NCT05292235	Chinese University of Hong Kong	—
Active Not Recruiting	Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization NCT04879940	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Recruiting	Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP NCT05678452	Al-Azhar University	N/A
Completed	Effectiveness of Smartconsent in Improving Understanding of Informed Consent NCT04856943	Bioaraba Health Research Institute	N/A
Suspended	Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. NCT05148156	Northwell Health	N/A
Unknown	Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder NCT05077852	Ankara Training and Research Hospital	—
Completed	Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain NCT05803096	Beth Israel Deaconess Medical Center	Phase 4
Unknown	Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Pr NCT02279615	St. Joseph's Healthcare Hamilton	Phase 4
Unknown	Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB NCT05494567	Mansoura University	Phase 4
Completed	Flexiva Pulse Registry NCT05027971	Boston Scientific Corporation	—
Recruiting	Customized TULSA-PRO Ablation Registry NCT05001477	Profound Medical Inc.	—
Suspended	Catheterless Water Vapor Therapy for the Treatment of BPH NCT04997369	Northwell Health	N/A
Unknown	Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial NCT06181175	Azienda Ospedaliero Universitaria Maggiore della Carita	N/A
Completed	Deprescribing Tamsulosin in Older Men NCT05415748	University of California, San Francisco	Phase 4
Completed	Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound NCT04853914	EDAP TMS S.A.	N/A
Unknown	Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP) NCT04807296	Centre hospitalier de l'Université de Montréal (CHUM)	N/A
Completed	Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With B NCT04831476	Elpen Pharmaceutical Co. Inc.	—
Unknown	Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH NCT04245566	Dominik Abt	Phase 3
Unknown	Intermittent Catheterization Versus Trial Without Catheter NCT05094947	Moscow State University of Medicine and Dentistry	N/A
Not Yet Recruiting	PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia NCT04807010	Society of Interventional Radiology Foundation	Phase 3
Completed	Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia NCT04947631	Dongkook Pharmaceutical Co., Ltd.	Phase 3
Completed	The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility NCT05222841	Catalysis SL	Phase 2 / Phase 3
Withdrawn	Ga-68 MAA Distribution in PAE Patients NCT04243824	University of North Carolina, Chapel Hill	EARLY_Phase 1
Completed	SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia NCT04826887	University of Kansas Medical Center	—
Active Not Recruiting	Economic Evaluation of Prostatic Urethral Lift NCT04726748	University Hospital, Bordeaux	—
Completed	Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Pr NCT04185441	EMS	Phase 3
Unknown	A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia NCT04802252	Qianfoshan Hospital	—
Completed	Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH) NCT05982444	Helwan University	N/A
Unknown	The Zenflow Spring System Safety and Performance Study (ZEST CAN) NCT04309695	Zenflow, Inc.	N/A
Active Not Recruiting	Comparing UroLift Experience Against Rezūm NCT04338776	NeoTract, Inc.	N/A
Completed	Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinica NCT04781049	San Carlo di Nancy Hospital	N/A
Unknown	UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue NCT04658056	PROCEPT BioRobotics	—
Unknown	Thulium Laser Versus Bipolar Enucleation of the Prostate NCT05200065	Cairo University	N/A
Completed	Anti-Androgen Treatment for COVID-19 NCT04446429	Applied Biology, Inc.	N/A
Completed	Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy NCT05416606	Helwan University	N/A
Not Yet Recruiting	Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study NCT04529369	Jewish General Hospital	N/A
Recruiting	5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy NCT04288427	Beth Israel Deaconess Medical Center	N/A
Completed	Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia NCT05531344	REMD Medical Technology	Phase 2 / Phase 3
Unknown	Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume NCT04912349	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Compari NCT04566588	University of Kansas Medical Center	N/A
Terminated	The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement NCT04340934	Chinese University of Hong Kong	N/A
Unknown	The Risk Factor and Outcome of Transient Incontinence After Prostate Enucleation Surgery NCT05116592	National Taiwan University Hospital	—
Unknown	Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for NCT04267445	University of Calgary	—
Completed	An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres NCT04272216	Terumo Medical Corporation	—
Active Not Recruiting	Optilume™ BPH Catheter System in Men With Symptomatic BPH NCT04131907	Urotronic Inc.	N/A
Unknown	Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperp NCT04236687	Germans Trias i Pujol Hospital	N/A
Completed	A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Do NCT04263987	Vanderbilt University Medical Center	Phase 3
Completed	Low Power ThULEP for Prostate Size More Than 80 gm NCT05494944	Kasr El Aini Hospital	N/A
Active Not Recruiting	Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Pr NCT04391114	Thunder Bay Regional Health Research Institute	N/A
Recruiting	Artery Embolization vs Operation of Benign Prostate Hyperplasia NCT04084938	Oslo University Hospital	N/A
Completed	Greenlight Vaporization vs Xpeeda Vaporesection NCT04386941	Thunder Bay Regional Health Research Institute	N/A
Completed	An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia NCT05422677	Hanmi Pharmaceutical Company Limited	—
Unknown	TURP; Complications and Outpatient Care NCT03959917	Umeå University	—
Completed	The ProVerum First in Man PROVE Study NCT03972371	ProVerum Medical	N/A
Terminated	Waterjet Prostate Ablation NCT03938194	Chinese University of Hong Kong	N/A
Unknown	Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia NCT04352257	Kafrelsheikh University	—
Completed	Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal NCT03887871	Chong Kun Dang Pharmaceutical	Phase 1
Completed	Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers NCT03887858	Chong Kun Dang Pharmaceutical	Phase 1
Completed	The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia NCT03829904	Taipei Veterans General Hospital, Taiwan	Phase 1 / Phase 2
Unknown	The Zenflow Spring System EU Safety and Performance Study NCT03577236	Zenflow, Inc.	N/A
Terminated	Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Pros NCT03768765	University of Kansas Medical Center	—
Unknown	Safety and Feasibility of the XFLO Expander System (Mercury) NCT03758222	MedeonBio, Inc.	N/A
Completed	Urodynamic Feasibility Study Utilizing the UroLift® System NCT04271020	NeoTract, Inc.	N/A
Completed	Embosphere® PROstate Post Market Study NCT03527589	Merit Medical Systems, Inc.	—
Unknown	The Zenflow Spring System Safety, Performance and Effectiveness Study NCT03595735	Zenflow, Inc.	N/A
Unknown	Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands NCT03583034	IRCCS San Raffaele	—
Unknown	Focal Laser Ablation for Benign Prostatic Hyperplasia NCT04044573	University of Rome Tor Vergata	N/A
Completed	A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH NCT04146103	Saint-Joseph University	N/A
Completed	Comparison of Holmium Laser Enucleation Prostatectomy and Open Transvesical Prostatectomy in Large Prostate NCT04471155	Ain Shams University	N/A
Completed	Prostatic Urethral Lift in Subject With Acute Urinary Retention NCT03194737	NeoTract, Inc.	N/A
Withdrawn	Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) i NCT03043222	St. Louis University	N/A
Unknown	Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship NCT03479359	Changhai Hospital	—
Terminated	Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) NCT03297398	OPKO Health, Inc.	Phase 2
Unknown	Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate NCT03503721	Salzburger Landeskliniken	N/A
Completed	Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter NCT03423979	Urotronic Inc.	Phase 2
Recruiting	Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) NCT03297281	Clinique Pasteur	N/A
Terminated	Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP) NCT03062111	Boston University	N/A
Unknown	Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate NCT03157726	Zhujiang Hospital	N/A
Completed	Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) NCT04107896	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 4
Completed	MRI Guided Transurethral HIFU for Various Prostate Diseases NCT03350529	Turku University Hospital	N/A
Completed	Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia I NCT04308070	PROCEPT BioRobotics	N/A
Recruiting	Database for the Assessment of Efficacy and Safety of BPH Treatment NCT03521648	Dominik Abt	—
Completed	Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH NCT03179670	RECORDATI GROUP	—
Unknown	Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enla NCT03109925	University Hospital Southampton NHS Foundation Trust	Phase 2
Completed	High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH NCT03264482	Mansoura University	N/A
Completed	Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia I NCT03125889	PROCEPT BioRobotics	N/A
Completed	Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil NCT03240939	Yuyu Pharma, Inc.	Phase 1
Terminated	Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia NCT02918227	University Hospital, Limoges	N/A
Completed	Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia NCT02930889	University of Minnesota	N/A
Terminated	To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BP NCT02962674	ProstaCare Singapore Pte. Ltd.	N/A
Completed	Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia NCT03125863	PROCEPT BioRobotics	N/A
Completed	Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia NCT02869971	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking NCT02757768	Astellas Pharma Global Development, Inc.	Phase 4
Completed	Real World Data on Management of Male LUTS NCT03075449	Boehringer Ingelheim	—
Unknown	The Zenflow Spring System Feasibility and Safety Study NCT02786290	Zenflow, Inc.	N/A
Withdrawn	Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate NCT02822963	National Cheng-Kung University Hospital	—
Unknown	The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptom NCT02862483	IlDong Pharmaceutical Co Ltd	Phase 3
Completed	Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS NCT02972268	Jeil Pharmaceutical Co., Ltd.	Phase 3
Completed	Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy NCT03912766	Medical University of Lodz	—
Unknown	Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contractu NCT02869061	Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation	Phase 1 / Phase 2
Completed	Study to Compare the Safety and Pharmacokinetics of CKD-397 NCT02645890	Chong Kun Dang Pharmaceutical	Phase 1
Completed	The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil NCT03144596	Kocatepe University	Phase 4
Withdrawn	Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment. NCT02566551	Group of Research in Minimally Invasive Techniques	N/A
Completed	Safety and Efficacy of OCL 503 in Prostate Artery Embolization NCT02509975	IMBiotechnologies Ltd.	N/A
Withdrawn	Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysf NCT01967251	Takeda	Phase 2
Completed	Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients NCT03246880	Chong Kun Dang Pharmaceutical	Phase 3
Completed	Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. NCT02524236	Beni-Suef University	EARLY_Phase 1
Completed	The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. NCT02494349	Jeil Pharmaceutical Co., Ltd.	Phase 1
Completed	Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells NCT02425800	Wake Forest University Health Sciences	—
Completed	Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers NCT02447367	Jeil Pharmaceutical Co., Ltd.	Phase 1
Completed	A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign NCT02431754	Eli Lilly and Company	Phase 4
Completed	A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules NCT02667938	Hanmi Pharmaceutical Company Limited	Phase 3
Completed	Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia NCT02977832	Fondazione IRCCS Policlinico San Matteo di Pavia	N/A
Completed	AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia NCT03167294	PROCEPT BioRobotics	N/A
Recruiting	Protocollo N 2014 - Benign Prostatic Hyperplasia NCT06182189	IRCCS San Raffaele	—
Unknown	Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams NCT02167009	Tampa General Hospital	N/A
Completed	A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lo NCT02326454	Light Sciences Oncology	Phase 2
Unknown	Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency NCT02293759	Mansoura University	Phase 4
Completed	GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Pros NCT02283684	Mansoura University	Phase 4
Completed	Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyper NCT02206243	Jena University Hospital	—
Completed	Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin NCT02180997	Jeil Pharmaceutical Co., Ltd.	Phase 1
Completed	Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) NCT02167919	University of North Carolina, Chapel Hill	N/A
Completed	GreenLight XPS Laser System Retrospective Chart Review NCT02139969	Boston Scientific Corporation	—
Terminated	Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benig NCT01931605	University Hospital, Rouen	Phase 3
Completed	Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients W NCT02303769	GL Pharm Tech Corporation	Phase 3
Completed	Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin NCT02239484	Hanmi Pharmaceutical Company Limited	Phase 1
Completed	Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Pro NCT01963312	Fundacion Miguel Servet	N/A
Completed	Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostati NCT02054013	Daniel Stephan Engeler	N/A
Completed	Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study NCT02051036	JUNGNAM KWON	N/A
Completed	Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia NCT02106182	JW Pharmaceutical	Phase 4
Terminated	Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Ele NCT02019030	Olympus Corporation of the Americas	—
Completed	Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia NCT02313233	Golden Biotechnology Corporation	N/A
Completed	Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System NCT02029560	JW Pharmaceutical	—
Completed	Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 f NCT01966614	Sophiris Bio Corp	Phase 3
Completed	Prostate Embolization for Benign Prostatic Hyperplasia NCT01924988	James B. Spies, MD	Phase 1 / Phase 2
Completed	Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hype NCT01939184	Warner Chilcott	Phase 2
Terminated	Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2 NCT01534351	Merck Sharp & Dohme LLC	Phase 3
Terminated	Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia NCT01789840	Merit Medical Systems, Inc.	N/A
Completed	Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) NCT01912339	Boston Scientific Corporation	N/A
Completed	Application of DWI in Diagnosis of Prostate Cancer NCT04962269	Peking University Third Hospital	—
Completed	2013 Annual National Digital Rectal Exam (DRE) Day Study NCT01886547	St. Luke's Medical Center, Philippines	—
Completed	The Changes of Urine Growth Factors Level NCT06282731	En Chu Kong Hospital	EARLY_Phase 1
Withdrawn	Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres NCT02679430	Antonios Likourezos	N/A
Terminated	JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) NCT01830829	Dr. J. Curtis Nickel	Phase 3
Completed	Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-002 NCT01846793	Nymox Corporation	Phase 3
Completed	UroLift System TOlerability and ReCovery When Administering Local Anesthesia NCT01876706	NeoTract, Inc.	N/A
Completed	Ultrasound-Guided Photoselective Vaporization of the Prostate NCT02346500	Johns Hopkins University	EARLY_Phase 1
Completed	Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and NCT01716104	Materia Medica Holding	Phase 3
Completed	Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels NCT01678313	Buddhist Tzu Chi General Hospital	Phase 2
Completed	Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS NCT01589263	VA Office of Research and Development	Phase 2
Completed	Rezum FIM Optimization Study NCT02940392	Boston Scientific Corporation	N/A
Completed	Rezum I Pilot Study for Benign Prostatic Hyperplasia NCT02943070	Boston Scientific Corporation	N/A
Completed	QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) NCT01534793	Assistance Publique - Hôpitaux de Paris	—
Completed	BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia NCT01533038	NeoTract, Inc.	N/A
Completed	Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia NCT06380062	Universität des Saarlandes	—
Completed	Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) NCT01460342	Eli Lilly and Company	Phase 3
Completed	Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) NCT01454349	Sophiris Bio Corp	Phase 1 / Phase 2
Completed	Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NCT01438775	Nymox Corporation	Phase 3
Unknown	Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperp NCT01404637	Samsung Medical Center	N/A
Completed	Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon NCT01604148	Samsung Medical Center	—
Completed	Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia NCT01757769	RECORDATI GROUP	Phase 4
Completed	Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of NCT01218672	Boston Scientific Corporation	N/A
Withdrawn	BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) NCT01520441	The University of Texas Health Science Center, Houston	EARLY_Phase 1
Unknown	3D Recording of a Trans-rectal Prostate Biopsy NCT01314456	HaEmek Medical Center, Israel	N/A
Completed	The Safety and Effectiveness of UroLift: LIFT Pivotal Study NCT01294150	NeoTract, Inc.	N/A
Completed	Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) NCT01002222	Health Ever Bio-Tech Co., Ltd.	Phase 3
Completed	Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Pros NCT01301599	Samsung Medical Center	Phase 4
Completed	Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) NCT01259531	JW Pharmaceutical	Phase 4
Completed	Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome NCT01826617	St. Luke's Medical Center, Philippines	—
Unknown	An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Pro NCT01351987	Taipei Medical University WanFang Hospital	—
Completed	A Study in Benign Prostatic Hyperplasia NCT01152190	Eli Lilly and Company	Phase 3
Completed	A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms NCT01139762	Eli Lilly and Company	Phase 3
Completed	Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms NCT01002274	Health Ever Bio-Tech Co., Ltd.	Phase 3
Completed	Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Comb NCT01435954	GlaxoSmithKline	—
Completed	Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hy NCT01107392	Allergan	Phase 2
Completed	A Study of Tadalafil in Benign Prostatic Hyperplasia NCT01183650	Eli Lilly and Company	Phase 1
Completed	MCS in the Treatment of Lower Urinary Tract Symptoms NCT01002417	Health Ever Bio-Tech Co., Ltd.	Phase 2 / Phase 3
Completed	Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms NCT01002664	Health Ever Bio-Tech Co., Ltd.	Phase 3
Completed	Korean Practice Patterns for Screening PCA(Prostate Cancer) NCT01371513	GlaxoSmithKline	—
Completed	Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) NCT01021332	Astellas Pharma Europe B.V.	Phase 3
Terminated	A Study in Men With Benign Prostatic Hyperplasia NCT01097707	Eli Lilly and Company	Phase 2
Unknown	Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate NCT01073241	Southwest Hospital, China	N/A
Completed	Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms NCT01018511	Astellas Pharma Europe B.V.	Phase 3
Completed	Economic Analyses of the REDUCE Trial NCT01337258	GlaxoSmithKline	—
Completed	A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyp NCT00894517	Allergan	Phase 1 / Phase 2
Unknown	Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg NCT00954889	Samsung Medical Center	N/A
Completed	Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia NCT00962390	Ausio Pharmaceuticals, LLC	Phase 2
Completed	Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB NCT00922506	Samsung Medical Center	Phase 4
Completed	Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign NCT00918034	Light Sciences Oncology	Phase 2
Completed	Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NCT00918983	Nymox Corporation	Phase 3
Completed	A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia NCT00855582	Eli Lilly and Company	Phase 3
Completed	A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blocke NCT00848081	Eli Lilly and Company	Phase 3
Completed	Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia NCT00861757	Eli Lilly and Company	Phase 3
Completed	EC905 Pharmacokinetic Profile Study NCT02634489	Astellas Pharma Europe B.V.	Phase 1
Completed	Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily NCT00827242	Eli Lilly and Company	Phase 3
Completed	Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperpl NCT00889707	Sophiris Bio Corp	Phase 2
Completed	Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compa NCT00797394	innoVactiv Inc.	Phase 2
Completed	Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Op NCT00783094	Eli Lilly and Company	Phase 2
Completed	Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH NCT00877669	Samsung Medical Center	Phase 2
Completed	Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia NCT00771394	Astellas Pharma Inc	Phase 4
Completed	Temperature Mapping of the Prostate With the Wallterm™ System NCT00662350	Pnn Medical A/S	—
Completed	Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prost NCT00709488	Light Sciences Oncology	Phase 1
Withdrawn	The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia NCT00687388	Samsung Medical Center	Phase 4
Unknown	A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subj NCT00690950	Urologic Consultants of Southeastern PA	Phase 4
Completed	A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia NCT01387893	Kaiser Permanente	N/A
Withdrawn	On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoin NCT00564460	University of Alberta	Phase 3
Completed	Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate NCT00880672	Seoul National University Hospital	Phase 4
Completed	PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate NCT00527371	St. Joseph's Healthcare Hamilton	N/A
Completed	TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management NCT01043588	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) NCT00527605	GlaxoSmithKline	Phase 3
Completed	Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) NCT00540124	Eli Lilly and Company	Phase 2
Terminated	MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia NCT00501371	Health Ever Bio-Tech Co., Ltd.	Phase 3
Completed	A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization NCT00465101	American Medical Systems	Phase 4
Terminated	Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter NCT00421421	GlaxoSmithKline	Phase 4
Completed	Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia NCT00730418	Samsung Medical Center	N/A
Completed	Botulinum Toxin Injection for the Management of BPH NCT00451191	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2
Completed	Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia NCT00386009	Eli Lilly and Company	Phase 2
Terminated	A Clinical Trial Comparing Laser TURP With and Without Dutasteride. NCT00431626	Northwestern University	Phase 3
Completed	Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia NCT00384930	Eli Lilly and Company	Phase 2 / Phase 3
Completed	Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction NCT00827814	Samsung Medical Center	Phase 4
Completed	Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH NCT00347061	Sanofi	Phase 3

Showing the 300 most recent trials. Use search for older records.